Product identification
Medicine name:
RABISIN vet, injeksjonsvæske, suspensjon Vaksine mot rabies til dyr (inaktivert)
Active substance:
- Rabies virus, Inactivated
Target species:
-
Horse
-
Dog
-
Cat
-
Cattle
-
Sheep
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, Inactivated2.09/log10 optical density501.00international unit(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Horse
-
All relevant tissues0day
-
-
Cattle
-
All relevant tissues0day
-
Milk0day
-
-
Sheep
-
All relevant tissues0day
-
-
-
Subcutaneous use
-
Cattle
-
All relevant tissues0day
-
Milk0day
-
-
Horse
-
All relevant tissues0day
-
-
Sheep
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Available in:
-
Norway
Package description:
- Available only in Norwegian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Authorisation number:
- 1997-00851
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Norwegian (PDF)
Published on: 18/06/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Norwegian (PDF)
Published on: 18/06/2025